Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

This page contains information about current funding opportunities with Industry. If you are thinking of applying, please read all terms and conditions and feel free to get in touch with the named Oxford contact to talk more about the opportunity. Opportunities are not vetted at the stage of being included on this page. The page is updated on a monthly basis and is not exhaustive.

Seeking Translational early discovery research in Haematology

Company: BioMarin Pharmaceutical

Brief: BioMarin Pharmaceutical are looking for early discovery research that involve targets with strong genetic evidence in the area of haematology.

Submission deadline: 21 February 2022

How to apply: Please contact who will be able to help you apply via the in-part platform

Further information about the BioMarin Pharmaceutical call

Asahi Kasei Open Innovation Call

Company: Asahi Kasei

Brief: Inviting proposals on collaborative research projects including new targets, new candidates, therapeutic concepts, research tools, drug formulation and delivery systems in the following areas:

  • Autoimmune disease
  • Critical care medicine
  • Neurodegenerative disease
  • Pain and Neuropathy
  • Bone disease
  • Drug Discovery Platform Technology

Funding available: up to 200,000 USD (per project, per year)

Application period: from 6 January to 28 February 2022

How to apply: apply via the Asahi Kasei Open Innovation Call website

Sanofi iTech Award Initiative

We are pleased to announce that we have partnered with Sanofi to participate in their iTech Award initiative. This scheme will award up to 16 100,0000€ awards for a range of innovation projects.

The iTech Awards program is a booster to transform breakthrough technologies developed by academics and startups into innovative solutions for the benefit of patients. Capitalizing on the success of the pilot phase in France in 2020-2021, Sanofi is launching the iTech Awards 2021-2022 across Europe. Sanofi's main objectives are to identify and de-risk ambitious projects in new technologies, to build trustful relationships with pioneers in innovation and to prepare further collaborations.

Sanofi iTech Awards is a 1-year program consisting of:

  • Seed funding of 100,000€
  • Dedicated support of a Sanofi scientific expert
  • Stepping stone to further collaboration

Areas of interest:

  • Large molecule research
  • Integrated drug discovery
  • Drug metabolism
  • Real world evidence development
  • Data & Data sciences R&D
  • Innovation in biologics chemistry, manufacturing and control
  • Genomic medicine
  • Vaccines

Deadline: 2 February 2022

How to apply: If you are interested in applying, please contact in the Business Partnerships Office.


On this page